Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | APP | P05067 | 1/20 | 0.35 |
| ▸ | HTR1A | P08908 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.31 |
| ▸ | CTSL | P07711 | 1/20 | 0.31 |
| ▸ | CTSS | P25774 | 1/20 | 0.31 |
| ▸ | CTSK | P43235 | 1/20 | 0.31 |
| ▸ | POLB | P06746 | 2/20 | 0.30 |
| ▸ | NPC1 | O15118 | 1/20 | 0.30 |
| ▸ | RAB9A | P51151 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3655490 | 1.00 | APP (0.35) | APPHTR1AALDH1A1CTSLCTSS | |
| SCHEMBL3659486 | 0.86 | CTSS (0.34) | APPALDH1A1CTSLCTSSCTSK | |
| SCHEMBL3768078 | 0.86 | CTSS (0.34) | APPALDH1A1CTSLCTSSCTSK | |
| SCHEMBL3659827 | 0.85 | APP (0.33) | APPALDH1A1 | |
| SCHEMBL3764832 | 0.85 | APP (0.33) | APPALDH1A1 | |
| SCHEMBL3660887 | 0.84 | CTSL (0.35) | APPALDH1A1CTSLCTSSCTSK | |
| SCHEMBL3769102 | 0.84 | CTSL (0.35) | APPALDH1A1CTSLCTSSCTSK | |
| SCHEMBL3770862 | 0.84 | L3MBTL1 (0.36) | APPALDH1A1 | |
| SCHEMBL3663647 | 0.84 | L3MBTL1 (0.36) | APPALDH1A1 | |
| SCHEMBL3660502 | 0.83 | ALDH1A1 (0.47) | APPHTR1AALDH1A1POLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100311790-A1 | AMIDE COMPOUNDS AND PLANT DISEASE CONTROLLING METHOD USING SAME | SUMITOMO CHIEMCAL COMPANY LIMITED (JP) | 2010-12-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100311790-A1 | AMIDE COMPOUNDS AND PLANT DISEASE CONTROLLING METHOD USING SAME | ATL3, NAT1, C5 | APP 2380/4885HTR1A 2686/4885ALDH1A1 2906/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.